<?xml version="1.0" encoding="UTF-8"?>
<p id="Par43">There has been increasing interest in the use of medicinal cannabinoids over recent years, particularly for the relief of symptoms in palliative care patients [
 <xref ref-type="bibr" rid="CR3">3</xref>]. Recent legislative change in several Australian states provided pathways for the use of medicinal cannabinoids for a range of indications including chemotherapy-induced nausea and vomiting (CINV), resistant epilepsy, pain and spasticity in multiple sclerosis, and symptoms associated with terminal illness [
 <xref ref-type="bibr" rid="CR4">4</xref>].
</p>
